Reassortant Rotaviruses As Potential Live Rotavirus Vaccine Candidates

Overview

Journal J Virol

Publisher American Society for Microbiology

Date 1985 Mar 1

PMID 2983101

Citations 78

Authors

K Midthun

H B Greenberg

Y Hoshino

A Z Kapikian

R G Wyatt

R M Chanock

Affiliations

Soon will be listed here.

Abstract

A series of reassortants was isolated from coinfection of cell cultures with a wild-type animal rotavirus and a "noncultivatable" human rotavirus. Wild-type bovine rotavirus (UK strain) was reassorted with human rotavirus strains D, DS-1, and P; wild-type rhesus rotavirus was reassorted with human rotavirus strains D and DS-1. The D, DS-1, and P strains represent human rotavirus serotypes 1, 2, and 3, respectively. Monospecific antiserum (to bovine rotavirus, NCDV strain) or a set of monoclonal antibodies to the major outer capsid neutralization glycoprotein, VP7 (of the rhesus rotavirus), was used to select for reassortants with human rotavirus neutralization specificity. This selection technique yielded many reassortants which received only the gene segment coding for the major neutralization protein from the human rotavirus parent, whereas the remaining genes were derived from the animal rotavirus parent. Single human rotavirus gene substitution reassortants of this sort represent potential live vaccine strains.

Citing Articles

Rapid production of recombinant rotaviruses by overexpression of NSP2 and NSP5 genes with modified nucleotide sequences.

Kanai Y, Kotaki T, Sakai S, Ishisaka T, Matsuo K, Yoshida Y J Virol. 2024; 98(12):e0099624.

PMID: 39494903 PMC: 11650980. DOI: 10.1128/jvi.00996-24.

Human Rotavirus Reverse Genetics Systems to Study Viral Replication and Pathogenesis.

Komoto S, Fukuda S, Murata T, Taniguchi K Viruses. 2021; 13(9).

PMID: 34578372 PMC: 8473093. DOI: 10.3390/v13091791.

Safety and immunogenicity of a novel oral hexavalent rotavirus vaccine：a phase I clinical trial.

Wu Z, Li Q, Zhou H, Duan K, Gao Z, Zhang X Hum Vaccin Immunother. 2021; 17(7):2311-2318.

PMID: 33545015 PMC: 8189138. DOI: 10.1080/21645515.2020.1861874.

Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Folorunso O, Sebolai O Vaccines (Basel). 2020; 8(3).

PMID: 32604982 PMC: 7565912. DOI: 10.3390/vaccines8030341.

Generation of Simian Rotavirus Reassortants with VP4- and VP7-Encoding Genome Segments from Human Strains Circulating in Africa Using Reverse Genetics.

Falkenhagen A, Patzina-Mehling C, Gadicherla A, Strydom A, ONeill H, Johne R Viruses. 2020; 12(2).

PMID: 32054092 PMC: 7077283. DOI: 10.3390/v12020201.

References

Laemmli U . Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970; 227(5259):680-5. DOI: 10.1038/227680a0. View

Hoshino Y, Wyatt R, Greenberg H, Flores J, Kapikian A . Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis. 1984; 149(5):694-702. DOI: 10.1093/infdis/149.5.694. View

Bridger J, Woode G . Neonatal calf diarrhoea: identification of a reovirus-like (rotavirus) agent in faeces by immunofluorescence and immune electron microscopy. Br Vet J. 1975; 131(5):528-35. View

Kalica A, Garon C, Wyatt R, Mebus C, van Kirk D, Chanock R . Differentiation of human and calf reoviruslike agents associated with diarrhea using polyacrylamide gel electrophoresis of RNA. Virology. 1976; 74(1):86-92. DOI: 10.1016/0042-6822(76)90131-8. View

Stuker G, Oshiro L, SCHMIDT N . Antigenic comparisons of two new rotaviruses from rhesus monkeys. J Clin Microbiol. 1980; 11(2):202-3. PMC: 273357. DOI: 10.1128/jcm.11.2.202-203.1980. View

Kapikian A, Wyatt R, Greenberg H, Kalica A, Kim H, BRANDT C . Approaches to immunization of infants and young children against gastroenteritis due to rotaviruses. Rev Infect Dis. 1980; 2(3):459-69. DOI: 10.1093/clinids/2.3.459. View

Greenberg H, Kalica A, Wyatt R, Jones R, Kapikian A, Chanock R . Rescue of noncultivatable human rotavirus by gene reassortment during mixed infection with ts mutants of a cultivatable bovine rotavirus. Proc Natl Acad Sci U S A. 1981; 78(1):420-4. PMC: 319065. DOI: 10.1073/pnas.78.1.420. View

Kalica A, Greenberg H, Wyatt R, Flores J, Sereno M, Kapikian A . Genes of human (strain Wa) and bovine (strain UK) rotaviruses that code for neutralization and subgroup antigens. Virology. 1981; 112(2):385-90. DOI: 10.1016/0042-6822(81)90285-3. View

Greenberg H, Wyatt R, Kapikian A, Kalica A, Flores J, Jones R . Rescue and serotypic characterization of noncultivable human rotavirus by gene reassortment. Infect Immun. 1982; 37(1):104-9. PMC: 347496. DOI: 10.1128/iai.37.1.104-109.1982. View

10.

Flores J, Greenberg H, Myslinski J, Kalica A, Wyatt R, Kapikian A . Use of transcription probes for genotyping rotavirus reassortants. Virology. 1982; 121(2):288-95. DOI: 10.1016/0042-6822(82)90168-4. View

11.

Kalica A, Flores J, Greenberg H . Identification of the rotaviral gene that codes for hemagglutination and protease-enhanced plaque formation. Virology. 1983; 125(1):194-205. DOI: 10.1016/0042-6822(83)90073-9. View

12.

Greenberg H, Flores J, Kalica A, Wyatt R, Jones R . Gene coding assignments for growth restriction, neutralization and subgroup specificities of the W and DS-1 strains of human rotavirus. J Gen Virol. 1983; 64 (Pt 2):313-20. DOI: 10.1099/0022-1317-64-2-313. View

13.

Wyatt R, JAMES Jr H, Pittman A, Hoshino Y, Greenberg H, Kalica A . Direct isolation in cell culture of human rotaviruses and their characterization into four serotypes. J Clin Microbiol. 1983; 18(2):310-7. PMC: 270797. DOI: 10.1128/jcm.18.2.310-317.1983. View

14.

Greenberg H, Valdesuso J, Van Wyke K, Midthun K, Walsh M, McAULIFFE V . Production and preliminary characterization of monoclonal antibodies directed at two surface proteins of rhesus rotavirus. J Virol. 1983; 47(2):267-75. PMC: 255258. DOI: 10.1128/JVI.47.2.267-275.1983. View

15.

Vesikari T, Isolauri E, Delem A, Dhondt E, Andre F, Zissis G . Immunogenicity and safety of live oral attenuated bovine rotavirus vaccine strain RIT 4237 in adults and young children. Lancet. 1983; 2(8354):807-11. DOI: 10.1016/s0140-6736(83)90734-1. View

16.

Wyatt R, Kapikian A, Greenberg H, Kalica A, Flores J, Hoshino Y . Development of vaccines against rotavirus disease. Prog Food Nutr Sci. 1983; 7(3-4):189-92. View

17.

Vesikari T, Isolauri E, Dhondt E, Delem A, Andre F, Zissis G . Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet. 1984; 1(8384):977-81. DOI: 10.1016/s0140-6736(84)92323-7. View

18.

Petricciani J, HOPPS H, LORENZ D . Subhuman primate diploid cells: possible substrates for production of virus vaccines. Science. 1971; 174(4013):1025-7. DOI: 10.1126/science.174.4013.1025. View